Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 2050 of 3284 entries
View as:

Establish FeNO Cut-off Value for Predicting Budesonide-formoterol Response in Chronic Cough Suggestive of CVA Patients.

Phase: N/A Priority: Normal
NCT ID: NCT06590740 Org: User:
Start: 10/25/24 End: 07/30/25 Due: 07/30/26

A Global Study to Compare the Effects of Fulvestrant and Arimidex in a Subset of Patients With Breast Cancer.

Phase: N/A Priority: Normal
NCT ID: NCT01602380 Org: User:
Start: 10/17/12 End: 08/06/27 Due: 08/06/28

Evaluation of Succinate Metoprolol on Heart Rate in the Stable Angina Patients

Phase: N/A Priority: Normal
NCT ID: NCT01213173 Org: User:
Start: 10/31/10 End: 09/30/11 Due: 09/30/12

A Study to Evaluate a Potassium Normalization Treatment Regimen Including Sodium Zirconium Cyclosilicate (ZS) Among Patients With S-K ≥5.8

Phase: N/A Priority: Normal
NCT ID: NCT03337477 Org: User:
Start: 02/13/18 End: 12/21/18 Due: 12/21/19

Treatment and Biomarker Testing Patterns,Treatment Outcomes in a/m NSCLC With and Without Actionable Genomic Alterations

Phase: N/A Priority: Normal
NCT ID: NCT06245837 Org: User:
Start: 03/20/24 End: 06/30/26 Due: 06/30/27

A Study of NT-175 in Adult Subjects With Unresectable, Advanced, and/or Metastatic Solid Tumors That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation

Phase: N/A Priority: Normal
NCT ID: NCT05877599 Org: User:
Start: 07/12/23 End: 08/01/39 Due: 08/01/40

A Study to Assess the Mass Balance and ADME of [14C]AZD5004 and the Absolute Bioavailability of AZD5004

Phase: N/A Priority: Normal
NCT ID: NCT06857695 Org: User:
Start: 03/06/25 End: 05/05/25 Due: 05/05/26

NIS to Examine the Effectiveness and Safety of Durvalumab and Olaparib in Patients With Endometrial Cancer (DUOLife)

Phase: N/A Priority: Normal
NCT ID: NCT06890273 Org: User:
Start: 05/20/25 End: 09/30/28 Due: 09/30/29

[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]

Phase: N/A Priority: Normal
NCT ID: NCT01994720 Org: User:
Start: 01/07/14 End: 03/02/16 Due: 03/02/17

Efficacy and Safety of MEDI7352 in Participants With Painful Diabetic Neuropathy

Phase: N/A Priority: Normal
NCT ID: NCT03755934 Org: User:
Start: 11/19/18 End: 06/29/23 Due: 06/29/24

Study to Evaluate the Efficacy and Safety of Benralizumab in Adult Patients With Mild to Moderate Persistent Asthma

Phase: N/A Priority: Normal
NCT ID: NCT02322775 Org: User:
Start: 02/02/15 End: 10/07/15 Due: 10/07/16

A Study to Investigate the Relative Bioavailability of 2 Different Formulations of AZD4144, the Effect of Food and Omeprazole on the Pharmacokinetics of AZD4144 in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT06948006 Org: User:
Start: 04/23/25 End: 07/11/25 Due: 07/11/26

Chronic Posterior Laryngitis With Suspected Laryngopharyngeal Reflux

Phase: N/A Priority: Normal
NCT ID: NCT00628667 Org: User:
Start: 02/28/02 End: 03/31/03 Due: 03/31/04

Durvalumab After Chemoradiotherapy in Limited Stage Small Cell Lung Cancer.

Phase: N/A Priority: Normal
NCT ID: NCT06992609 Org: User:
Start: 06/30/25 End: 06/30/29 Due: 06/30/30

OPTIMISE-CKD Study_current Clinical Landscape in Spain

Phase: N/A Priority: Normal
NCT ID: NCT06614712 Org: User:
Start: 12/04/24 End: 06/30/25 Due: 06/30/26

Treatment Protocol to Monitor the Safety of a 200 mg Dose of Bicalutamide in Patients With Advanced Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00846976 Org: User:
Start: 12/31/94 End: 06/30/13 Due: 06/30/14

Direct Statin Comparison of LDL-C Values: an Evaluation of Rosuvastatin Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00239330 Org: User:
Start: 06/30/03 End: 02/28/05 Due: 02/28/06

An Observational Prospective Cohort Study for Long-term Management of Hyperkalemia in Patients With Chronic Kidney Disease or Heart Failure

Phase: N/A Priority: Normal
NCT ID: NCT05297409 Org: User:
Start: 05/21/22 End: 08/28/24 Due: 08/28/25

Acalabrutinib Safety Study in Untreated and Relapsed or Refractory Chronic Lymphocytic Leukemia Patients

Phase: N/A Priority: Normal
NCT ID: NCT04008706 Org: User:
Start: 09/17/19 End: 09/01/25 Due: 09/01/26

Safety and Efficacy of Dapagliflozin in Triple Therapy to Treat Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01646320 Org: User:
Start: 09/30/12 End: 02/28/15 Due: 02/28/16

Congenital Malformations and Maternal Use of Anti-hypertensive Medication in the United Kingdom

Phase: N/A Priority: Normal
NCT ID: NCT02459990 Org: User:
Start: 06/30/15 End: 06/30/15 Due: 06/30/16

National Survey on Infiltrative Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00696527 Org: User:
Start: 06/30/07 End: 07/31/08 Due: 07/31/09

Randomized Study Of CP-675,206 or Best Supportive Care Immediately After Platinum-Based Therapy For Non-Small Cell Lung Cancer (NSCLC)

Phase: N/A Priority: Normal
NCT ID: NCT00312975 Org: User:
Start: 05/31/06 End: 02/28/10 Due: 02/28/11

Faslodex Post Marketing Surveillance

Phase: N/A Priority: Normal
NCT ID: NCT00860561 Org: User:
Start: 01/31/09 End: 10/31/13 Due: 10/31/14

A Randomized, Open-Label, Comparative 3-Way Treatment Crossover Study of 24-Hour Intragastric pH Profile of Once Daily Oral Administration of Esomeprazole 40mg, Lansoprazole 30mg, and Pantoprazole 40mg at Steady State in NSAID-Using Patients

Phase: N/A Priority: Normal
NCT ID: NCT00625274 Org: User:
Start: 06/30/04 End: 11/30/04 Due: 11/30/05